The Greater Houston biopharmaceutical corridor—anchored by the world-renowned Texas Medical Center (TMC), the new TMC Helix Park innovation campus, Levit Green, and the rapidly growing biomanufacturing cluster in The Woodlands—has evolved into a formidable global hub for advanced life science research. While Houston historically established leadership in oncology and cell therapy, the regional therapeutic landscape is undergoing a massive paradigm shift toward oligonucleotide therapeutics, including small interfering RNA (siRNA), antisense oligonucleotides (ASOs), microRNA inhibitors, and lipid nanoparticle (LNP)-encapsulated mRNA constructs.
Biotechnology firms, clinical-stage biopharmas, and academic research institutions across Houston require reliable, highly scalable, and structurally validated Active Pharmaceutical Ingredients (APIs). Transitioning an oligonucleotide candidate from benchtop proof-of-concept at institutions like MD Anderson Cancer Center or Baylor College of Medicine to Phase I–III clinical trials demands uncompromising chemical purity, rigorous analytical characterization, and batch-to-batch reproducibility. This is where strategic international manufacturing partners provide transformative value to Houston-based sponsors.
The supply chain for complex nucleic acid APIs demands more than basic chemical synthesis. It requires strict adherence to solid-phase phosphoramidite chemistry, specialized sequence modification (such as 2'-OMe, 2'-F, and phosphorothioate backbones), GalNAc-conjugation techniques, and seamless compliance with US FDA Regulatory Filing standards (DMF Type II). Partnering with certified global factories allows Houston organizations to reduce API procurement costs by 30% to 50% while guaranteeing cGMP compliance.
Whether your organization is developing target-specific knockdown therapies for rare metabolic disorders, hypercholesterolemia, systemic amyloidosis, or oncology applications, securing a trustworthy supply chain for bulk therapeutic peptides and oligonucleotide raw materials is the cornerstone of clinical speed and commercial viability.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
End-to-end technical consultation, analytical method validation, and formulation setup tailored for emerging therapeutic modalities.
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Send Inquiry Now
Utilizing state-of-the-art automated synthesizer platforms, we execute step-by-step assembly using high-purity phosphoramidite building blocks. Trityl monitoring ensures coupling efficiency exceeds 99.2% per cycle.
Precision insertion of 2'-O-methyl (2'-OMe), 2'-fluoro (2'-F), phosphorothioate (PS) backbone linkages, and locked nucleic acids (LNA) to maximize nuclease resistance and target affinity.
Advanced solution-phase and solid-support conjugation of N-Acetylgalactosamine (GalNAc) clusters, enabling targeted hepatic delivery via ASGPR receptors for siRNA molecules like Inclisiran.
Oligonucleotide API manufacturing presents unique impurity profiles, primarily consisting of (n-1) shortmers, (n+1) longmers, depurinated species, and persistent organic solvents. Our modern 250,000 m² chemical infrastructure leverages multi-stage downstream isolation:
One of the primary vulnerabilities facing biotechnology organizations in the Houston market is the raw material bottleneck associated with oligonucleotide production. Critical starting materials—such as specialty phosphoramidites, modified nucleosides, solid supports (CPG and polystyrene), and coupling activators—frequently experience global supply constraints.
Gentolex solves this operational challenge through deep upstream integration across our massive production footprint. By controlling the synthesis of chemical building blocks internally, we offer Houston biopharmas guaranteed campaign scheduling, continuous scale-up capability, and substantial cost reductions.
| Metric | Standard Local Vendors | Gentolex Integrated |
|---|---|---|
| Batch Capacity | Gram to 500g limits | Gram to Multi-Kg |
| Raw Material Lead Time | 8–16 Weeks | 2–4 Weeks (In-House) |
| Cost per Gram (siRNA/ASO) | Premium Regional Pricing | 30%–50% Savings |
| Regulatory Documentation | Variable Standard CoA | Full DMF / eCTD Dossier |
Houston's research institutes lead groundbreaking studies in atherosclerosis, hypercholesterolemia, and ANGPTL3/PCSK9 gene silencing. We supply bulk APIs such as Inclisiran Sodium and Zilebesiran with strict endotoxin and purity controls.
Therapies aimed at hereditary angioedema (HAE), acute hepatic porphyria, and hemophilia demand highly specialized antisense molecules like Donidalorsen, Givosiran, and Fitusiran manufactured under strict ISO/cGMP standards.
Combining nucleic acid stability with peptide targeted ligands, our platform supports next-generation metabolic therapeutics, including high-purity GLP-1/GIP agonists (Tirzepatide, Semaglutide, Retatrutide) and specialized mitochondria-targeting peptides.
Introduction to Selank Acetate API Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed through neuropharmacological research...
View Details
Trusted Thymosin Beta-4 API Manufacturer and Global Peptide Supplier As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies...
View Details
Introduction BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair, gastrointestinal protection, and inflammatory regulation...
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation. Semax, a synthetic peptide derived from an ACTH fragment...
View Details
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, and SS31, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane to support cellular bioenergetics...
View Details
Accelerate your clinical drug pipeline in Houston with certified cGMP peptide and nucleic acid APIs. Contact our technical team today for DMF availability and custom quote.
Send Inquiry Now
